FasL-triggered death of Jurkat cells requires caspase 8-induced, ATP-dependent cross-talk between Fas and the purinergic receptor P2X7

Journal of Cellular Physiology

Volumn 228, Issue 2, 2013, Pages 485-493

  Aguirre, Adam ^a   Shoji, Kenji F ^b   Sáez, Juan C ^b,c   Henríquez, Mauricio ^a   Quest, Andrew Fg ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Centro Interdisciplinario de Neurociencias de Valparaíso   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANNEXIN; APYRASE; BRILLIANT BLUE; CASPASE 3; CASPASE 8; CASPASE 9; FAS LIGAND; PANNEXIN I HEMICHANNEL; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL DEATH; CELL STIMULATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROLYSIS; LEUKEMIA CELL LINE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANTIGENS, CD95; APOPTOSIS; APYRASE; CASPASE 3; CASPASE 8; CASPASE 9; CONNEXINS; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; NERVE TISSUE PROTEINS; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7; ROSANILINE DYES; SIGNAL TRANSDUCTION;

EID: 84868019293     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24159     Document Type: Article

References (42)

1. Adinolfi E, Melchiorri L, Falzoni S, Chiozzi P, Morelli A, Tieghi A, Cuneo A, Castoldi G, Di Virgilio F, Baricordi OR. 2002. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99:706-708.
2. Anselmi F, Hernandez VH, Crispino G, Seydel A, Ortolano S, Roper SD, Kessaris N, Richardson W, Rickheit G, Filippov MA, Monyer H, Mammano F. 2008. ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear. PNAS 105:18770-18775.
3. Aswad F, Dennert G. 2006. P2X7 receptor expression levels determine lethal effects of a purine based danger signal in T lymphocytes. Cell Immunol 243:58-65.
4. Bal-Price A, Moneer Z, Brown GC. 2002. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40:312-323.
5. Berger A, Sexton K, Bogyo M. 2006. Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity. Cell Res 16:961-963.
6. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213-232.
7. Bruzzone R, Barbe MT, Jakob NJ, Monyer H. 2005. Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem 92:1033-1043.
8. Burnstock G. 2006. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58-86.
9. Chekeni F, Elliott M, Sandilos J, Walk S, Kinchen J, Lazarowski E, Armstrong A, Penuela S, Laird D, Salvesen G, Isakson B, Bayliss D, Ravichandran K. 2010. Pannexin 1 channels mediate "find-me" signal release and membrane permeability during apoptosis. Nature 467:863-867.
10. Di Virgilio F, Chiozzi P, Falzoni S, Ferrari D, Sanz JM, Venketaraman V, Baricordi OR. 1998. Cytolytic P2X purinoceptors. Cell Death Differ 5:191-199.
11. Elliott M, Chekeni F, Trampont P, Lazarowski E, Kadl A, Walk S, Park D, Woodson R, Ostankovich M, Sharma P, Lysiak J, Harden T, Leitinger N, Ravichandran K. 2009. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282-286.
12. Hammond CL, Marchan R, Krance SM, Ballatori N. 2007. Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J Biol Chem 282:14337-14347.
13. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770-776.
14. Hetz CA, Hunn M, Rojas P, Torres V, Leyton L, Quest AF. 2002. Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: Onset of necrosis is associated with delayed ceramide increase. J Cell Sci 115:4671-4683.
15. Hill LM, Gavala ML, Lenertz LY, Bertics PJ. 2010. Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes. J Immunol 185:3028-3034.
16. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer J, Schroter M, Burns K, Mattmann C, Rimoldi D, French L, Tschopp J. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195.
17. Kim YS, Park GB, Song HK, Hur I, Lee HK, Kang JS, Hahm E, Lee WJ, Hur DY. 2007. Cross-linking of CD54 on Burkitt lymphoma cell line Raji and Ramos induces FasL expression by reactive oxygen species and apoptosis of adjacent cells in Fas/FasL interaction. J Immunother 30:727-739.
18. Lenertz LY, Gavala ML, Hill LM, Bertics PJ. 2009. Cell signaling via the P2X(7) nucleotide receptor: Linkage to ROS production, gene transcription, and receptor trafficking. Purinergic Signal 5:175-187.
19. Lenertz LY, Gavala ML, Zhu Y, Bertics PJ. 2011. Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions. Immunol Res 50:22-38.
20. Locovei S, Scemes E, Qiu F, Spray D, Dahl G. 2007. Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett 581:483-488.
21. Maroto R, Hamill OP. 2001. Brefeldin A block of integrin-dependent mechanosensitive ATP release from Xenopus oocytes reveals a novel mechanism of mechanotransduction. J Biol Chem 276:23867-23872.
22. North RA. 2002. Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067.
23. Parpura V, Scemes E, Spray DC. 2004. Mechanisms of glutamate release from astrocytes: Gap junction "hemichannels, "purinergic receptors and exocytotic release. Neurochem Int 45:259-264.
24. Pelegrin P. 2011. Many ways to dilate the P2X7 receptor pore. Br J Pharmacol 163:908-911.
25. Pelegrin P, Surprenant A. 2006. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071-5082.
26. Pelegrin P, Surprenant A. 2009. The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta release. Purinergic Signal 5:129-137.
27. Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L, Takano T, Tian GF, Goldman SA, Nedergaard M. 2009. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci USA 106:12489-12493.
28. Peter ME, Krammer PH. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10:26-35.
29. Pulte D, Olson KE, Broekman MJ, Islam N, Ballard HS, Furman RR, Olson AE, Marcus AJ. 2007. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia. J Transl Med 5:23.
30. Qiu F, Wang J, Dahl G. 2011. Alanine substitution scanning of pannexin1 reveals amino acid residues mediating ATP sensitivity. Purinergic Signal 8:81-90.
31. Samraj AK, Keil E, Ueffing N, Schulze-Osthoff K, Schmitz I. 2006. Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95-mediated apoptosis. J Biol Chem 281:29652-29659.
32. Sandilos JK, Chiu Y-HH, Chekeni FB, Armstrong AJ, Walk SF, Ravichandran KS, Bayliss DA. 2012. Pannexin 1, an ATP release channel, is activated by caspase cleavage of its pore-associated C terminal autoinhibitory region. J Biol Chem M111:323378.
33. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli K, Debatin K, Krammer P, Peter M. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675-1687.
34. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, Verderio C, Buer J, Scanziani E, Grassi F. 2008. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1:ra6.
35. Silverman W, Locovei S, Dahl G. 2008. Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Cell Physiol 295:C761-C767.
36. Strasser A, Jost PJ, Nagata S. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30:180-192.
37. Tokunaga A, Tsukimoto M, Harada H, Moriyama Y, Kojima S. 2010. Involvement of SLC17A9-dependent vesicular exocytosis in the mechanism of ATP release during T cell activation. J Biol Chem 285:17406-17416.
38. Tsukimoto M, Maehata M, Harada H, Ikari A, Takagi K, Degawa M. 2006. P2X7 receptor-dependent cell death is modulated during murine T cell maturation and mediated by dual signaling pathways. J Immunol 177:2842-2850.
39. van Steensel B, van Binnendijk EP, Hornsby CD, van der Voort HT, Krozowski ZS, de Kloet ER, van Driel R. 1996. Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J Cell Sci 109:787-792.
40. Villena J, Henriquez M, Torres V, Moraga F, Diaz-Elizondo J, Arredondo C, Chiong M, Olea-Azar C, Stutzin A, Lavandero S, Quest AF. 2008. Ceramide-induced formation of ROS and ATP depletion trigger necrosis in lymphoid cells. Free Radic Biol Med 44:1146-1160.
41. Yip L, Woehrle T, Corriden R, Hirsh M, Chen Y, Inoue Y, Ferrari V, Insel PA, Junger WG. 2009. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J 23:1685-1693.
42. Yoon M, Lee H, Lee Y, Kim J, Park J, Chang W, Shin H, Kim D. 2007. Extracellular ATP is involved in the induction of apoptosis in murine hematopoietic cells. Biol Pharm Bull 30:671-676.